Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02196584 · ClinicalTrials.gov registry record
Clinical Evaluation of the RAVI-Guide
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 55
- Enrollment target
NCT02196584: Completed study, sponsored by Medical College of Wisconsin.
NCT02196584 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02196584 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections Aims: To compare patient acceptance and procedural complication rates of the RAVI-Guide with those of the conventional lid speculum and caliper approach
Primary Outcome
A pain severity scale of 0 to 10, with 0 being no pain, and 10 being worst imaginable pain, will be used to grade pain severity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-06 |
What the finished NCT02196584 record still lists
NCT02196584 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02196584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02196584 about?
NCT02196584 is a clinical study titled "Clinical Evaluation of the RAVI-Guide". Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections Aims: To compare patient acceptance and procedural complication rates of the RAVI-Guide with those of the conventional lid speculum and caliper approach
What is the current status of trial NCT02196584?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2014-08. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02196584?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia